Emerge Diagnostics Launches Remote Employee Wellness Program Focused on Musculoskeletal Health – Yahoo Finance

Share Article

Virtual Soft Tissue Injury Evaluations, Yoga and other Preventive and Screening Services Now Available in First-of-its-Kind Telehealth Platform
CARLSBAD, Calif., Feb. 7, 2022 /PRNewswire/ — Emerge Diagnostics, a medical diagnostic provider and technology company specializing in soft tissue injury management, today announced the launch of a breakthrough wellness offering that allows employers, industry groups and trade associations to offer a range of healthcare services focused on musculoskeletal and preventive health via telemedicine.
We're making it possible for employers to offer wellness services that target the root causes of pain and fatigue.
The new Emerge Diagnostics Wellness Platform is the first-of-its-kind to combine Electrodiagnostic Functional Assessment (EFA) technology in conjunction with unique virtual yoga instruction, telemedicine and discounted healthcare benefits – including radiology, mental health and lab work. Over the last 15 years of its commercial use, Emerge Diagnostics' EFA technology has gained recognition as the gold standard in soft tissue injury diagnostics and prevention. It uses electromyography in conjunction with functional assessments to pinpoint musculoskeletal conditions and enhance site-specific treatment. By offering this capability in conjunction with preventative measures such as yoga, fitness coaching and telehealth access, the Emerge Diagnostics Wellness Platform addresses the unique challenges workers and their families are facing in the current environment.
"With the prospect of long-term remote work rapidly becoming a certainty, persistent labor shortages and the erratic spread of the COVID-19 virus creating untenable burdens for America's workers and their families, employers are staring down an employee wellness crisis," said Mary Reaston, Ph.D., Co-Founder and Chief Science Officer of Emerge Diagnostics. "With this new platform, we're making it possible for employers, industry groups and trade associations to give employees and their families comprehensive wellness services that target the root causes of back and neck strains, headache, repetitive stress injuries and overall fatigue and burnout that have become the collateral damage of the COVID-19 pandemic."
Delivered via a partnership between Emerge Diagnostics, Yoga Your Way and Healthcare2U, the comprehensive wellness platform helps employers drive retention and improve outcomes by delivering affordable, flexible preventive care to employees and their families.
"Work has fundamentally changed over the past two years and employee benefits plans need to evolve with new forms of preventive care to address the needs of the new marketplace," said David Riker, CEO of Emerge Diagnostics. "Employers need innovative solutions to help keep their employees healthy, energized and engaged in an environment in which everyone is trying to do more with less. We believe this platform helps to address that need at a cost and delivery format that is accessible to everyone."
Delivered as a low-cost monthly subscription that covers employees and dependents, the program is designed to help families not only stay prepared if they need medical advice, but also stay healthy and fit in mind and body with its focus on musculoskeletal wellness and preventative care. By bringing together industry leading providers of soft-tissue diagnostics, telehealth primary care services and yoga and fitness, the new Emerge Diagnostics Wellness Platform creates a truly unique offering in the employee benefits space.
For more information, please visit www.emergedx.com.
About Emerge Diagnostics
Emerge Diagnostics Inc. provides technology and services to optimize soft-tissue care, allowing patients to get back to living faster. The company's Electrodiagnostic Functional Assessment (EFA) technology is now the gold standard for soft-tissue injury diagnosis and treatment, using a host of proprietary technologies to assess root causes—and from virtually anywhere in the world. Headquartered in Carlsbad, CA, Emerge Diagnostics serves clients in several industries, including trucking, healthcare and sports, providing the information necessary to treat soft-tissue injuries more accurately and build care management and monitoring programs rooted in objective data. www.emergedx.com
About Healthcare2U
Healthcare2U is a membership-based, direct primary care organization that provides employers of all sizes with unlimited primary and urgent care, nationwide. Our integrated model redefines the delivery of healthcare by providing a service for the early detection, treatment, and management of acute and chronic conditions, before the onset of serious illness. https://healthc2u.com/
About Yoga Your Way
We understand the yoga journey can be new and challenging even if you are an experienced practitioner, so we have developed unique vignettes that not only break down each pose with benefits, but each vignette also includes modifications to make each pose accessible to everybody.
Our Virtual Yoga Classes are also unique! You can follow along with our certified instructors, or you can turn your camera on to allow the instructor to see you and offer enhancements and modifications. It's like having a private instructor in your own home. We have a perfect match for everybody, every experience level and mood. https://yogayourway.fitness/
John Roderick
J. Roderick Public Relations
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/emerge-diagnostics-launches-remote-employee-wellness-program-focused-on-musculoskeletal-health-301475839.html
SOURCE Emerge Diagnostics
Fourth-quarter sales of Xpovio were encouraging, but top-line results from another trial were a little disappointing.
Biotech stocks are going through a historic drawdown at the moment. Nearly 400 publicly traded biotech companies have lost 40% or more of their value in just the past six months. Many of these beaten-down biotech stocks will ultimately rebound.
The stock markets have started off 2022 with increased volatility, and that’s opened up opportunities for investors – especially for investors willing to shoulder some additional risk. The sharp decline in January lowered prices, while the rapid swings we’ve seen in recent trading sessions makes it possible to take advantage of the lowered entry point. A market situation like this should naturally bring investors’ attention to the penny stocks. These low-cost equities, typically priced below $5
Is Pfizer stock a buy or a sell after the company guided to $98 billion to $102 billion in 2022 sales, lagging estimates? Is PFE stock a buy or a sell?
Biomerica Inc (NASDAQ: BMRA) has announced topline results from its InFoods IBS diagnostic-guided therapy (DGT) endpoint clinical trial. The trial showed statistically significant improvements in multiple endpoints in the Intent-to-Treat population. The InFoods DGT uses a simple blood test to identify patient-specific foods that may alleviate Irritable Bowel Syndrome (IBS) symptoms such as pain, bloating, diarrhea, and constipation when removed from the diet. Related: Biomerica's Shares Gain As
If Amazon can deliver more efficient health care services, the potential is enormous for fueling its growth engine and Amazon stock.
But the new report is not all bad news. Working from home can also be healthy if employers and workers respect personal boundaries and establish certain habits..
Dr. Peter Hotez, Co-Director of the Center for Vaccine Development at Texas Children’s Hospital, joins Yahoo Finance Live to discuss the development of a new coronavirus vaccine, global vaccine inequity, and vaccine technology.
Medicare is a government-sponsored program designed to help eligible seniors and others pay for healthcare. Medicare Advantage plans offer an alternative to Original Medicare, which includes Part A and Part B coverage. The Medicare Advantage Open Enrollment Period is your … Continue reading → The post 2022 Medicare Advantage Open Enrollment Period appeared first on SmartAsset Blog.
During the past two years, Immunonome has received more than $17.5 million from the U.S. Department of Defense’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense to support the company's development of the new drug candidate.
Amazon on Tuesday announced its telemedicine service has expanded nationwide in the United States, a new extension of the firm's empire that has steadily gone far beyond e-commerce.
"If the shots were given away for free because they’re life-saving, why isn’t insulin free?" the actor tweeted on Monday.
Medicare is designed to help with healthcare expenses for people aged 65 and older, certain younger people with disabilities and people with end-stage renal disease. The Medicare Extra Help program offers additional assistance with paying for prescription drugs for people … Continue reading → The post Medicare Extra Help Basics appeared first on SmartAsset Blog.
Cingulate Inc (NASDAQ: CING) plans to initiate Phase 3 studies for CTx-1301 for Attention Deficit/Hyperactivity Disorder (ADHD) in 2022. ADHD is a chronic neurobiological and developmental disorder. The planned studies include a fixed-dose pediatric & adolescent safety and efficacy study, a dose-optimization study extension, and a pediatric safety & efficacy study to assess the onset and duration of efficacy. Specifically, the pivotal, fixed-dose study will begin in Q2 of 2022. These studies are
Despite lawsuit filed against Dr Robert Karas by four inmates, local officials have praised him for a ‘job well done’ Inmates said in lawsuit against Dr Karas they were given ivermectin to treat Covid-19 as a form of ‘medical experiment’. Photograph: Bloomberg/Getty Images An Arkansas doctor accused of prescribing ivermectin to inmates in his state without their consent has been praised by local officials for a “job well done” despite widespread outrage at his actions. In January, the Arkansas c
Bausch Health, Canada, part of Bausch Health Companies Inc. (NYSE: BHC) (TSX: BHC), ("Bausch Health" or the "Company") today announced the availability through pharmacies across Canada of its new prescription treatment TRULANCE® (plecanatide).
It's no secret that coronavirus vaccines are hot-selling medicines for which there's a massive market. Pfizer is expected to make $36 billion in 2021 alone from sales of its coronavirus shot, Comirnaty, and it's hard to see demand falling while the pandemic rages. If a competitor were to develop a new product that doesn't fall victim to the same pitfalls, Pfizer's dominance might come to an end.
Novo Nordisk CEO Lars Fruergaard Jørgensen joins Yahoo Finance Live to discuss the future of obesity and diabetes treatments, innovation in these fields, supply issues, drug prices, and the complexity of the U.S. health care system.
There’s still a lot to be learned about the long-term effects of the coronavirus — otherwise known as “long COVID.”
The governors of at least five states are planning to drop face mask mandates for students and school employees or others in indoor public places in an effort to restore a level of normalcy for their residents, against the advice of the nation's main public health agency which continues to recommend their use.


You might also like

Surviving 2nd wave of corona

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort